Despite the growing number of data stressing the relevance of MICAL2 to human cancer, it is worth noting that CCG-1423 (1, Figure 1), namely a small molecule that inhibits the SRF/MRTF-A pathway, is the only MICAL2 inhibitor known to date. The gene discussed is MICAL2; the disease is cancer.